To: sense who wrote (174282 ) 7/6/2021 4:36:49 AM From: TobagoJack Read Replies (1) | Respond to of 217842 In the meantime, Team Israel reports in, and the news is not-positive and I am more concerned today than I was yesterday, as suspicion earlier seemingly revealed to be possibly true, that nothing works against rapidly evolving CoVid IOW, the jab-after-jab approach is failing to work, and the lock-everywhere-down cannot work for long, even as letting it burn through is asking for trouble, because we are effectively looking at different virus, much like lions and tigers, alligators and snakes, etc etc Right ahead be school openings and winter flu season.haaretz.com Israel Says Pfizer Vaccine Less Effective in Preventing Delta Variant Infection Health Ministry says COVID vaccine at 64 percent effectiveness in preventing infections, but experts differ Ministry notes vaccine is still 93 percent effective in preventing hospitalizations and severe symptoms timesofisrael.com Israel confirms vaccine less effective against Delta variant, eyes third dose PM Bennett instructs Health Ministry to promote medical studies into long-term efficacy of Pfizer vaccine to provide decision-makers with ‘vital information’ on booster shots ft.com Pfizer vaccine less effective against Delta variant, Israeli study finds Data suggest jab is still 93% effective against serious illness and hospitalisation 13 hours ago A push to inoculate teenagers in Israel began last week. Cases have risen since all restrictions were lifted on June 1 © Reuters The BioNTech/Pfizer vaccine is less effective at halting the spread of the Delta variant than previous strains of coronavirus, according to a preliminary study by Israel’s health ministry. Data collected over the past month suggest the vaccine is 64 per cent effective at preventing infection among those who are fully inoculated, the ministry has found. Efficacy against previous strains of the virus was estimated at 94 per cent. However, the figures, first reported in the Ynet news portal, indicate the vaccine is 93 per cent effective against serious illness and hospitalisation.